Advanced search
1 file | 112.84 KB Add to list

Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients

Author
Organization
Keywords
VERSUS-HOST-DISEASE, PROPHYLAXIS, STABILITY

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 112.84 KB

Citation

Please use this url to cite or link to this publication:

MLA
Bauters, Tieneke et al. “Practical Considerations in the Use of Intravenous Tacrolimus in Hematopoietic Stem Cell Transplantation Patients.” JOURNAL OF ONCOLOGY PHARMACY PRACTICE 21.6 (2015): 478–480. Print.
APA
Bauters, T., Rayner, P., Therrien, R., Van Lancker, S., Bordon Cueto De Braem, M., Le Cordroch, M., Dhooge, C., et al. (2015). Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 21(6), 478–480.
Chicago author-date
Bauters, Tieneke, Patricia Rayner, Roxane Therrien, Sophie Van Lancker, Maria Bordon Cueto De Braem, Marion Le Cordroch, Catharina Dhooge, Yves Benoit, and Johan Vandenbroucke. 2015. “Practical Considerations in the Use of Intravenous Tacrolimus in Hematopoietic Stem Cell Transplantation Patients.” Journal of Oncology Pharmacy Practice 21 (6): 478–480.
Chicago author-date (all authors)
Bauters, Tieneke, Patricia Rayner, Roxane Therrien, Sophie Van Lancker, Maria Bordon Cueto De Braem, Marion Le Cordroch, Catharina Dhooge, Yves Benoit, and Johan Vandenbroucke. 2015. “Practical Considerations in the Use of Intravenous Tacrolimus in Hematopoietic Stem Cell Transplantation Patients.” Journal of Oncology Pharmacy Practice 21 (6): 478–480.
Vancouver
1.
Bauters T, Rayner P, Therrien R, Van Lancker S, Bordon Cueto De Braem M, Le Cordroch M, et al. Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2015;21(6):478–80.
IEEE
[1]
T. Bauters et al., “Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients,” JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol. 21, no. 6, pp. 478–480, 2015.
@article{5967919,
  author       = {Bauters, Tieneke and Rayner, Patricia and Therrien, Roxane and Van Lancker, Sophie and Bordon Cueto De Braem, Maria and Le Cordroch, Marion and Dhooge, Catharina and Benoit, Yves and Vandenbroucke, Johan},
  issn         = {1078-1552},
  journal      = {JOURNAL OF ONCOLOGY PHARMACY PRACTICE},
  keywords     = {VERSUS-HOST-DISEASE,PROPHYLAXIS,STABILITY},
  language     = {eng},
  number       = {6},
  pages        = {478--480},
  title        = {Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients},
  url          = {http://dx.doi.org/10.1177/1078155214531609},
  volume       = {21},
  year         = {2015},
}

Altmetric
View in Altmetric
Web of Science
Times cited: